Neuropathic osteoarthropathy affecting the vertebral joints, coded when Charcot joint destruction is localized to the spine and is not attributable to diabetes mellitus or neurosyphilis.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 12
- Region
- Spine
Documentation tips
What should appear in the chart to support M14.68.
Source · Editorial brief grounded in 4 cited references ↓
- Name the underlying neurological condition explicitly (e.g., syringomyelia, alcoholic neuropathy) — M14.68 requires a sequenced-first etiology code and cannot stand alone.
- Confirm and document exclusion of diabetic etiology and neurosyphilis; without that exclusion, payers can challenge the code and redirect to E08–E13 with .610 or A52.16.
- Specify the vertebral level or region (cervical, thoracic, lumbar, sacral) in the note — the code doesn't carry that granularity, but clinical documentation supports medical necessity and audit defense.
- Record imaging findings that support neuropathic joint disease: subchondral sclerosis, joint fragmentation, vertebral debris, or vacuum phenomenon on CT or MRI.
- Document the presence or absence of pain — classic Charcot arthropathy is disproportionately painless relative to the degree of radiographic destruction, and noting this supports the clinical diagnosis.
Related CPT procedures
Procedure codes commonly billed with M14.68. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M14.68 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Sequencing M14.68 as the principal diagnosis — it is a manifestation code and must be listed after the underlying etiology code; placing it first will trigger a claim edit.
- Using M14.68 when diabetes is the documented cause — the Excludes1 at M14.6 prohibits any M14.6x code when diabetic Charcot joint is present; use E08–E13 with .610 instead.
- Confusing M14.68 with degenerative spondylosis or spondyloarthropathy codes (M47.x, M46.x) — neuropathic joint destruction has a distinct pathophysiology and requires documented neurological etiology.
- Omitting the etiology code entirely and billing M14.68 alone — without a paired underlying condition code, claims lack the required etiology/manifestation pair and may deny.
- Defaulting to M14.60 (unspecified site) when the vertebrae are clearly documented — M14.68 is the billable site-specific code and should be used whenever spinal involvement is documented.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M14.68 applies to Charcot's joint (neuropathic arthropathy) of the vertebrae — progressive, painless destruction of spinal joints driven by loss of protective sensation from an underlying neurological condition. Common non-excluded etiologies include syringomyelia, alcoholic neuropathy, and other non-diabetic, non-syphilitic neuropathies.
Critical sequencing rule: M14.68 is a manifestation code ('in diseases classified elsewhere'). It must never be sequenced as the principal diagnosis. Code the underlying neurological etiology first, then M14.68 as the manifestation. Two hard Excludes1 blocks apply at the M14.6 parent level: Charcot's joint in diabetes mellitus (E08–E13 with .610) and Charcot's joint in tabes dorsalis (A52.16). If either of those conditions is the cause, M14.68 is the wrong code — full stop.
On the spinal side, distinguish M14.68 from degenerative disc disease, infectious spondylodiscitis, and inflammatory spondyloarthropathies. MRI and CT typically show subchondral sclerosis, facet joint destruction, vertebral fragmentation, or peri-articular debris consistent with neuropathic joint disease. Document the imaging findings and the confirmed neuropathic etiology to support M14.68 over a nonspecific degenerative or inflammatory spinal code.
Sibling codes
Other billable codes under M14.6 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01Can M14.68 be the first-listed diagnosis on a claim?
02What if the patient has both diabetes and vertebral Charcot joint — do I still use M14.68?
03Is neurosyphilis-related vertebral Charcot joint coded to M14.68?
04How does M14.68 differ from M14.60?
05What DRGs does M14.68 map to?
06Does M14.68 require a 7th-character extension?
07What other sites are in the M14.6 family if the Charcot involvement is not limited to the spine?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M14-/M14.68
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M14.68
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M14
Mira AI Scribe
Mira AI Scribe captures the underlying neuropathic condition (e.g., syringomyelia, alcoholic neuropathy), explicit exclusion of diabetic or syphilitic etiology, affected vertebral region, and imaging findings (joint fragmentation, subchondral sclerosis, vertebral debris) from the encounter note. This prevents incorrect principal-diagnosis sequencing, blocks misapplication of diabetic Charcot codes, and ensures the mandatory etiology/manifestation pair is complete before the claim is submitted.
See how Mira captures M14.68 documentation